BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 32768893)

  • 21. Depression, coronary events, platelet inhibition, and serotonin reuptake inhibitors.
    Nair GV; Gurbel PA; O'Connor CM; Gattis WA; Murugesan SR; Serebruany VL
    Am J Cardiol; 1999 Aug; 84(3):321-3, A8. PubMed ID: 10496443
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro effects of serotonin and noradrenaline reuptake inhibitors on human platelet adhesion and coagulation.
    Hallbäck I; Hägg S; Eriksson AC; Whiss PA
    Pharmacol Rep; 2012; 64(4):979-83. PubMed ID: 23087151
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dose-dependent influence of buspirone on the activities of selective serotonin reuptake inhibitors in the mouse forced swimming test.
    Redrobe JP; Bourin M
    Psychopharmacology (Berl); 1998 Jul; 138(2):198-206. PubMed ID: 9718290
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Empirically Supported Use of Psychiatric Medications in Adolescents and Adults with IBD.
    Thorkelson G; Bielefeldt K; Szigethy E
    Inflamm Bowel Dis; 2016 Jun; 22(6):1509-22. PubMed ID: 27167571
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sertraline. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depression and obsessive-compulsive disorder.
    Murdoch D; McTavish D
    Drugs; 1992 Oct; 44(4):604-24. PubMed ID: 1281075
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is the Antidepressant Activity of Selective Serotonin Reuptake Inhibitors Mediated by Nicotinic Acetylcholine Receptors?
    Arias HR; Targowska-Duda KM; García-Colunga J; Ortells MO
    Molecules; 2021 Apr; 26(8):. PubMed ID: 33917953
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of Antidepressants among Patients Diagnosed with Depression: A Scoping Review.
    Marasine NR; Sankhi S; Lamichhane R; Marasini NR; Dangi NB
    Biomed Res Int; 2021; 2021():6699028. PubMed ID: 33791379
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The anti-inflammatory role of SSRI and SNRI in the treatment of depression: a review of human and rodent research studies.
    Dionisie V; Filip GA; Manea MC; Manea M; Riga S
    Inflammopharmacology; 2021 Feb; 29(1):75-90. PubMed ID: 33164143
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antidepressant drugs: does it matter if they inhibit the reuptake of noradrenaline or serotonin?
    Eriksson E
    Acta Psychiatr Scand Suppl; 2000; 402():12-7. PubMed ID: 10901154
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent Developments on Future Antidepressant-related Serotonin Receptors.
    Amidfar M; Kim YK
    Curr Pharm Des; 2018; 24(22):2541-2548. PubMed ID: 30073919
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rapid response to selective serotonin reuptake inhibitors in post-COVID depression.
    Mazza MG; Zanardi R; Palladini M; Rovere-Querini P; Benedetti F
    Eur Neuropsychopharmacol; 2022 Jan; 54():1-6. PubMed ID: 34634679
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The dual-action hypothesis: does pharmacology matter?
    Shelton RC
    J Clin Psychiatry; 2004; 65 Suppl 17():5-10. PubMed ID: 15600376
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does selectivity matter?
    Deakin JF
    Int Clin Psychopharmacol; 1996 Mar; 11 Suppl 1():13-7. PubMed ID: 8732439
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selective serotonin reuptake inhibitor (SSRI) antidepressants reduce COVID-19 infection: prospects for use.
    Foletto VS; da Rosa TF; Serafin MB; Hörner R
    Eur J Clin Pharmacol; 2022 Oct; 78(10):1601-1611. PubMed ID: 35943535
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The clinicopharmacological case (5). serotonin reuptake inhibitor and 5-HT3-receptor antagonists: are there clinically relevant interactions?].
    Kind B; Fattinger K; Krähenbühl S; Meier-Abt PJ
    Praxis (Bern 1994); 1996 Nov; 85(46):1490-2. PubMed ID: 8984572
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antidepressant like effect of selective serotonin reuptake inhibitors involve modulation of imidazoline receptors by agmatine.
    Taksande BG; Kotagale NR; Tripathi SJ; Ugale RR; Chopde CT
    Neuropharmacology; 2009 Sep; 57(4):415-24. PubMed ID: 19589348
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Are the antiplatelet and profibrinolytic properties of selective serotonin-reuptake inhibitors relevant to their brain effects?
    Hoirisch-Clapauch S; Nardi AE; Gris JC; Brenner B
    Thromb Res; 2014 Jul; 134(1):11-6. PubMed ID: 24661990
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Variability in the effect of antidepressants upon Wfs1-deficient mice is dependent on the drugs' mechanism of actions.
    Reimets R; Raud S; Loomets M; Visnapuu T; Volke V; Reimets A; Plaas M; Vasar E
    Behav Brain Res; 2016 Jul; 308():53-63. PubMed ID: 27080063
    [TBL] [Abstract][Full Text] [Related]  

  • 39. WITHDRAWN: Treatment discontinuation with selective serotonin reuptake inhibitors (SSRIs) versus tricyclic antidepressants (TCAs).
    Barbui C; Hotopf M; Freemantle N; Boynton J; Churchill R; Eccles MP; Geddes JR; Hardy R; Lewis G; Mason JM
    Cochrane Database Syst Rev; 2007 Jul; (3):CD002791. PubMed ID: 17636706
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Augmentation effect of combination therapy of aripiprazole and antidepressants on forced swimming test in mice.
    Bourin M; Chenu F; Prica C; Hascoët M
    Psychopharmacology (Berl); 2009 Sep; 206(1):97-107. PubMed ID: 19517098
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.